MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2019 International Congress

    Association of active and passive smoking with Parkinson’s disease in women: the E3N cohort study

    M. Canonico, F. Artaud, D. Cerasuolo, I. Degaey, P. Gerbouin-Rerolle, A. Kowal, E. Roze, G. Severi, MC. Boutron-Ruault, A. Elbaz (Villejuif, France)

    Objective: To investigate the association of active and passive smoking with Parkinson’s disease (PD) incidence in women over 25y of follow-up. Background: PD is the…
  • 2019 International Congress

    Can Safinamide Help to Stabilize Dopaminergic Treatment in Parkinson’s Disease?

    B. Solano Vila, A. Cots Foraster, M. Montserrat Roses (Girona, Spain)

    Objective: After more than two years of clinical experience with safinamide  we want to retrospectively review its utility as a levodopa saver in our Parkinson's…
  • 2019 International Congress

    Life expectancy with and without Parkinson’s disease in the general population

    L. Dommershuijsen, A.. Ikram, K. Ikram (Rotterdam, Netherlands)

    Objective: To determine (1) the burden of Parkinson’s disease (PD) in the general population and (2) the life expectancy after the diagnosis of PD. Background:…
  • 2019 International Congress

    Spatial distribution of Parkinson’s disease in the Canton of Geneva, Switzerland

    V. Fleury, R. Himsl, S. Joost, N. Nicastro, I. Guessous, P. Burkhard (Lausanne, Switzerland)

    Objective: The objective of the study was to determine whether PD prevalence exhibit any spatial dependence in order to get hypothesis on PD risk or…
  • 2019 International Congress

    Use of ß2-adrenoreceptor agonist and antagonist drugs and risk of Parkinson’s disease

    F. Hopfner, M. Wod, G. Höglinger, M. Blaabjerg, T. Roesler, G. Kuhlenbäumer, K. Christensen, G. Deuschl, A. Pottegård (Kiel, Germany)

    Objective: Verification of the previously reported association between chronic use of β2-adrenoreceptor (β2AR) agonist and antagonist with reduced and increased risk of Parkinson’s disease (PD),…
  • 2019 International Congress

    Frequency and pattern of movement disorders in a Neurologic clinic in North Central Nigeria: a 3- year review

    E. Iwuozo, R. Obiako (Makurdi, Nigeria)

    Objective: This study evaluated the frequency and pattern of movement disorders in a neurology clinic in a tertiary hospital in North Central Nigeria over a…
  • 2019 International Congress

    Frequency of Cardiovascular Abnormalities in Mexican Patients with Early Parkinson´s Disease

    JA. Juárez, M. Violante, A. Arriaga, A. González, A. Salas, L. Vidal, R. Vicioso, C. Roa, I. López, M. Soto (Mexico, Mexico)

    Objective: To determine frequency of cardiovascular abnormalities and autonomic dysfunction in the early course of Parkinson's disease Background: Parkinson´s disease (PD) is a neurodegenerative disease…
  • 2019 International Congress

    Clostridium Difficile Infection and Risk of Parkinson’s Disease: A Swedish Population-Based Cohort Study

    X. Kang, A. Ploner, J. Ludvigsson, D. Williams, N. Pedersen, K. Wirdefeldt (Solna, Sweden)

    Objective: To examine whether individuals with a history of Clostridium difficile (C. diff) infection have an elevated risk of developing Parkinson’s disease (PD). Background: The…
  • 2019 International Congress

    Use of e-PROMs in Parkinson’s disease clinics: A qualitative study of healthcare professionals perceptions

    A. Khardali, L. Hughes, E. Lane (Cardiff, United Kingdom)

    Objective: To explore the views of PD healthcare professionals on the use of e-PROMs. Background: Assessment of motor AND non-motor symptoms are critical to the…
  • 2019 International Congress

    Long-term Yearly Trends of Feeding Tube Placement in Neurodegenerative Disorders

    D. Kim, R. Jones, A. D'Abreu, J. Friedman, U. Akbar (Providence, RI, USA)

    Objective: We sought to determine the incidence of feeding tube (FT) placement in Alzheimer's disease (AD), Parkinson's disease (PD), or amyotrophic lateral sclerosis(ALS) population, describe…
  • « Previous Page
  • 1
  • …
  • 1359
  • 1360
  • 1361
  • 1362
  • 1363
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley